Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study.

Li Z, Qi D, Chen J, Zhang C, Yi Z, Yuan C, Wang Z, Hong W, Yu S, Cui D, Fang Y.

Psychoneuroendocrinology. 2013 Jan;38(1):107-14. doi: 10.1016/j.psyneuen.2012.05.005. Epub 2012 Jun 7.

PMID:
22683211
2.

Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.

Wang Z, Li Z, Chen J, Huang J, Yuan C, Hong W, Yu S, Fang Y.

Genes Brain Behav. 2012 Jul;11(5):524-8. doi: 10.1111/j.1601-183X.2012.00797.x. Epub 2012 May 4.

3.

Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis.

Dervieux T, Wessels JA, Kremer JM, Padyukov L, Seddighzadeh M, Saevarsdottir S, van Vollenhoven RF, Klareskog L, Huizinga TW, Guchelaar HJ.

Pharmacogenet Genomics. 2012 Jan;22(1):1-9. doi: 10.1097/FPC.0b013e32834d3e0b.

PMID:
22044941
4.

Vulnerability to depression: from brain neuroplasticity to identification of biomarkers.

Blugeot A, Rivat C, Bouvier E, Molet J, Mouchard A, Zeau B, Bernard C, Benoliel JJ, Becker C.

J Neurosci. 2011 Sep 7;31(36):12889-99. doi: 10.1523/JNEUROSCI.1309-11.2011.

5.

A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.

Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Cui X, Calabrese JR, Gao K; OPERATION Study Team..

J Clin Psychopharmacol. 2011 Oct;31(5):638-42. doi: 10.1097/JCP.0b013e31822bb1d9.

PMID:
21869688
6.

Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression.

Toups MS, Greer TL, Kurian BT, Grannemann BD, Carmody TJ, Huebinger R, Rethorst C, Trivedi MH.

J Psychiatr Res. 2011 Oct;45(10):1301-6. doi: 10.1016/j.jpsychires.2011.05.002.

PMID:
21641002
7.

Therapeutic options in treatment-resistant depression.

Vieta E, Colom F.

Ann Med. 2011 Nov;43(7):512-30. doi: 10.3109/07853890.2011.583675. Epub 2011 May 31. Review.

PMID:
21623700
8.

Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis.

Fernandes BS, Gama CS, Ceresér KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F.

J Psychiatr Res. 2011 Aug;45(8):995-1004. doi: 10.1016/j.jpsychires.2011.03.002. Epub 2011 May 6. Review.

PMID:
21550050
9.

Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression.

Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE.

J Psychiatr Res. 2011 May;45(5):569-76. doi: 10.1016/j.jpsychires.2010.09.008. Epub 2010 Oct 16.

PMID:
20951997
10.

Integrating common and rare genetic variation in diverse human populations.

International HapMap 3 Consortium., Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, Peltonen L, Dermitzakis E, Bonnen PE, Altshuler DM, Gibbs RA, de Bakker PI, Deloukas P, Gabriel SB, Gwilliam R, Hunt S, Inouye M, Jia X, Palotie A, Parkin M, Whittaker P, Yu F, Chang K, Hawes A, Lewis LR, Ren Y, Wheeler D, Gibbs RA, Muzny DM, Barnes C, Darvishi K, Hurles M, Korn JM, Kristiansson K, Lee C, McCarrol SA, Nemesh J, Dermitzakis E, Keinan A, Montgomery SB, Pollack S, Price AL, Soranzo N, Bonnen PE, Gibbs RA, Gonzaga-Jauregui C, Keinan A, Price AL, Yu F, Anttila V, Brodeur W, Daly MJ, Leslie S, McVean G, Moutsianas L, Nguyen H, Schaffner SF, Zhang Q, Ghori MJ, McGinnis R, McLaren W, Pollack S, Price AL, Schaffner SF, Takeuchi F, Grossman SR, Shlyakhter I, Hostetter EB, Sabeti PC, Adebamowo CA, Foster MW, Gordon DR, Licinio J, Manca MC, Marshall PA, Matsuda I, Ngare D, Wang VO, Reddy D, Rotimi CN, Royal CD, Sharp RR, Zeng C, Brooks LD, McEwen JE.

Nature. 2010 Sep 2;467(7311):52-8. doi: 10.1038/nature09298.

11.

A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.

Serretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J.

J Affect Disord. 2011 Jan;128(1-2):56-63. doi: 10.1016/j.jad.2010.06.025.

PMID:
20643483
12.

Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA; OPERATION Study Team..

J Clin Psychopharmacol. 2010 Aug;30(4):357-64. doi: 10.1097/JCP.0b013e3181e7784f.

PMID:
20571433
13.

Cost burden of treatment resistance in patients with depression.

Gibson TB, Jing Y, Smith Carls G, Kim E, Bagalman JE, Burton WN, Tran QV, Pikalov A, Goetzel RZ.

Am J Manag Care. 2010 May;16(5):370-7.

14.

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.

Zou YF, Ye DQ, Feng XL, Su H, Pan FM, Liao FF.

Eur Neuropsychopharmacol. 2010 Aug;20(8):535-44. doi: 10.1016/j.euroneuro.2009.12.005. Epub 2010 Feb 18.

PMID:
20167454
15.

Therapeutic options for treatment-resistant depression.

Shelton RC, Osuntokun O, Heinloth AN, Corya SA.

CNS Drugs. 2010 Feb;24(2):131-61. doi: 10.2165/11530280-000000000-00000. Review.

PMID:
20088620
16.

Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.

Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP.

Neuropsychobiology. 2010;61(2):71-8. doi: 10.1159/000265132. Epub 2009 Dec 12.

PMID:
20016225
17.

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.

Kang RH, Chang HS, Wong ML, Choi MJ, Park JY, Lee HY, Jung IK, Joe SH, Kim L, Kim SH, Kim YK, Han CS, Ham BJ, Lee HJ, Ko YH, Lee MS, Lee MS.

J Psychopharmacol. 2010 Dec;24(12):1755-63. doi: 10.1177/0269881109105457. Epub 2009 Jun 3.

PMID:
19493959
18.

Genome-wide association study of bipolar disorder in European American and African American individuals.

Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W, Byerley W, Coryell W, Craig D, Edenberg HJ, Eskin E, Foroud T, Gershon E, Greenwood TA, Hipolito M, Koller DL, Lawson WB, Liu C, Lohoff F, McInnis MG, McMahon FJ, Mirel DB, Murray SS, Nievergelt C, Nurnberger J, Nwulia EA, Paschall J, Potash JB, Rice J, Schulze TG, Scheftner W, Panganiban C, Zaitlen N, Zandi PP, Zöllner S, Schork NJ, Kelsoe JR.

Mol Psychiatry. 2009 Aug;14(8):755-63. doi: 10.1038/mp.2009.43. Epub 2009 Jun 2.

19.

Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.

Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT.

J Psychiatr Res. 2009 Sep;43(14):1175-84. doi: 10.1016/j.jpsychires.2009.03.008. Epub 2009 Apr 18.

PMID:
19376528
20.

Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.

Piccinni A, Del Debbio A, Medda P, Bianchi C, Roncaglia I, Veltri A, Zanello S, Massimetti E, Origlia N, Domenici L, Marazziti D, Dell'Osso L.

Eur Neuropsychopharmacol. 2009 May;19(5):349-55. doi: 10.1016/j.euroneuro.2009.01.002. Epub 2009 Feb 15.

PMID:
19223156

Supplemental Content

Support Center